The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis
Open accessAbstract
Asbestos is the main cause of human malignant mesothelioma (MM). In vivo, macrophages phagocytize asbestos and, in response, release TNF-alpha and other cytokines that contribute to carcinogenesis through unknown mechanisms. In vitro, asbestos does not induce transformation of primary human mesothelial cells (HM); instead, asbestos is very cytotoxic to HM, causing extensive cell death. This finding raised an apparent paradox: How can asbestos cause MM if HM exposed to asbestos die? We found that asbestos induced the secretion of TNF-alpha and the expression of TNF-alpha receptor I in HM. Treatment of HM with TNF-alpha significantly reduced asbestos cytotoxicity. Through numerous technical approaches, including chemical inhibitors and small interfering RNA strategies, we demonstrate that, in HM, TNF-alpha activates NF-kappaB and that NF-kappaB activation leads to HM survival and resistance to the cytotoxic effects of asbestos. Our data show a critical role for TNF-alpha and NF-kappaB signaling in mediating HM responses to asbestos. TNF-alpha signaling through NF-kappaB-dependent mechanisms increases the percent of HM that survives asbestos exposure, thus increasing the pool of asbestos-damaged HM that are susceptible to malignant transformation. Cytogenetics supported this hypothesis, showing only rare, aberrant metaphases in HM exposed to asbestos and an increased mitotic rate with fewer irregular metaphases in HM exposed to both TNF-alpha and asbestos. Our findings provide a mechanistic rationale for the paradoxical inability of asbestos to transform HM in vitro, elucidate and underscore the role of TNF-alpha in asbestos pathogenesis in humans, and identify potential molecular targets for anti-MM prevention and therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TNF-α exerts its role acting on its receptor, TNF-R1, directly expressed on mesothelial cells’ plasma membrane. This interaction induces another autocrine release of TNF-α by mesothelial cells, the activation of NF-κB signaling, and the final result of skipping the apoptotic process of the injured mesothelial cells [54].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [54]
In the citing paper
“Asbestos-induced TNF-α release is associated with upregulation of TNF-α receptor on mesothelial cells, as well as NF-κB activation, suggesting that activation of pro-survival pathways by inflammatory cytokines may prolong the exposure of mesothelial cells to the genotoxic effects of asbestos fibers.126”
From Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? (2009) · cites this paper as [126]
In the citing paper
“Asbestos-induced TNF-α release is associated with upregulation of TNF-α receptor on mesothelial cells, as well as NF-κB activation, suggesting that activation of pro-survival pathways by inflammatory cytokines may prolong the exposure of mesothelial cells to the genotoxic effects of asbestos fibers.126”
From Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? (2009) · cites this paper as [126]
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Rubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., Sievers, C., Yang, L., Kopinja, J., Rooney, D. L., Zhang, M., Ihrig, M. M., McManus, M. T., et al. (2003) · Nature Genetics · doi:10.1038/ng1117 · Cited by 1,501
Cancer—Principles & Practice of Oncology
Rhoads, J. E. (1983) · PubMed Central · Cited by 1,466
Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, T., & Gerritsen, M. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21096 · Cited by 1,053
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
MOSSMAN, B. T., & CHURG, A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9707141 · Cited by 971
Self-citation
Research works printed but not linked: 12
- T. W. Hesterberg, C. J. Butterick, M. Oshimura, A. R. Brody, J. C. Barrett Cancer Res. 46, 5795–5802 (1986).
- N. Choe, S. Tanaka, W. Xia, D. R. Hemenway, V. L. Roggli, E. Kagan Environ. Health Perspect. 105, 1257–1260 (1997).
- K. E. Driscoll, J. M. Carter, D. G. Hassenbein, B. W. Howard Environ. Health Perspect. 105, 1159–1164 (1997).
- C. Xie, A. Reusse, J. Dai, K. Zay, J. Harnett, A. Churg Am. J. Physiol. 279, L608–L614 (2000).
- K. Donaldson, B. G. Miller, E. Sara, J. Slight, R. C. Brown Int. J. Exp. Pathol. 74, 243–250 (1993).
- M. Suganuma, S. Okabe, M. W. Marino, A. Sakai, E. Sueoka, H. Fujiki Cancer Res. 59, 4516–4518 (1999).
- M. Suganuma, S. Okabe, M. Kurusu, N. Iida, S. Ohshima, Y. Saeki, T. Kishimoto, H. Fujiki Int. J. Oncol. 20, 131–136 (2002).
- X. Hu, W. E. Janssen, L. C. Moscinski, M. Bryington, A. Dangsupa, N. Rezai-Zadeh, B. A. Babbin, K. S. Zuckerman Cancer Res. 61, 6290–6296 (2001).
- C. L. Scaife, J. Kuang, J. C. Wills, D. B. Trowbridge, P. Gray, B. M. Manning, E. J. Eichwald, R. A. Daynes, S. K. Kuwada Cancer Res. 62, 6870–6878 (2002).
- Y. M. Janssen, K. E. Driscoll, B. Howard, T. R. Quinlan, M. Treadwell, A. Barchowsky, B. T. Mossman Am. J. Pathol. 151, 389–401 (1997).
- S. Y. Tsai, B. Ardelt, T. C. Hsieh, Z. Darzynkiewicz, K. Shogen, J. M. Wu Int. J. Oncol. 25, 1745–1752 (2004).
- R. E. Rendall IARC Sci. Publ. 30, 87–96 (1980).
Cited by
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
Egeblad, M., Nakasone, E. S., & Werb, Z. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.012 · Cited by 1,234
Tumor necrosis factor and cancer, buddies or foes?
Wang, X., & Lin, Y. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00889.x · Cited by 730
Candido, J., & Hagemann, T. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9847-0 · Cited by 653
Metadata
- Authors
- Yang, H., Bocchetta, M., Kroczynska, B., Elmishad, A. G., Chen, Y., Liu, Z., Bubici, C., Mossman, B. T., Pass, H. I., Testa, J. R., Franzoso, G., & Carbone, M.
- Affiliations
- Loyola University Chicago (US)
- *Thoracic Oncology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL 60153;
- Fox Chase Cancer Center (US)
- University of Chicago (US)
- University of Vermont (US)
- New York University (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-07-05
- Volume
- 103
- Issue
- 27
- Pages
- 10397-10402
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1502469
- OpenAlex
- W1985690846
- Cited by
- 322
- References
- 52
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 9 · 2023: 20 · 2022: 26 · 2021: 21 · 2020: 12 · 2019: 11 · 2018: 6 · 2017: 13 · 2016: 11 · 2015: 16 · 2014: 17 · 2013: 19 · 2012: 22
- FWCI
- 19.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r01ca092657-06, 5p01ca114047-05)
- National Cancer Institute (R01-CA092657, R01CA106567, P01CA-114047)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- asbestos, TNF-α, NF-κB signaling, malignant mesothelioma, mesothelial cells, macrophage phagocytosis, malignant transformation, mitotic aberrations
- MeSH terms
- Asbestos, Cell Transformation, Neoplastic, Cells, Cultured, Chromosomes, Human, Epithelium, Humans, Metaphase, Tumor Necrosis Factor-alpha, Signal Transduction, NF-kappa B, RNA Interference, Receptors, Tumor Necrosis Factor, Type I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. https://app.cochat.ai/papers/10.1073/pnas.0604008103
- The paper
- Yang, H., Bocchetta, M., Kroczynska, B., Elmishad, A. G., Chen, Y., Liu, Z., Bubici, C., Mossman, B. T., Pass, H. I., Testa, J. R., Franzoso, G., & Carbone, M. (2006). TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0604008103
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.